CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

Updated on: April 09,2024

CAR T-cell therapy proves effective in first trial in patients with resistant multiple myeloma

by Roswell Park Comprehensive Cancer CenterCredit: CC0 Public DomainA therapy made of immune system T cells engineered to target a somewhat enigmatic cell protein called GPRC5D antigen produced impres

Updated on:April 09,2024

Drug combination for stage IV melanoma shows success in trial

by CU Anschutz Medical CampusMelanoma. Credit: Wikimedia Commons/National Cancer InstituteA new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year cli

Updated on: February 23,2024

Drug combination for stage IV melanoma shows success in trial

by CU Anschutz Medical CampusMelanoma. Credit: Wikimedia Commons/National Cancer InstituteA new multidrug treatment for patients with stage IV melanoma has proven effective after a three-year cli

Updated on:February 23,2024

Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on: March 01,2024

Findings could identify aggressive breast cancers that will respond to immunotherapy

by UNC Lineberger Comprehensive Cancer CenterUNC Lineberger’s Charles M. Perou, PhD. Credit: UNCUniversity of North Carolina Lineberger Comprehensive Cancer Center researchers have discovered a p

Updated on:March 01,2024

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

Updated on: May 17,2024

A compound effective against chemotherapy-resistant cancer cells identified

by Hokkaido UniversityThe administration of the compound 10580 caused human GICs (red) transplanted in mice to undergo apoptosis, a type of cell death (green). Credit: Hokkaido UniversityA compou

Updated on:May 17,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on: February 24,2024

Research finds alternating estrogen and anti-estrogen therapies effective in treating metastatic breast cancer

by Dartmouth HealthCredit: Unsplash/CC0 Public DomainAdvanced or metastatic estrogen receptor-positive (ER+) breast cancer is commonly treated with drugs that block the estrogen receptor. However

Updated on:February 24,2024

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine

Updated on: February 24,2024

Largest-ever atlas of normal breast cells brings unprecedented insights into mammary biology

by University of Texas M. D. Anderson Cancer CenterCredit: Unsplash/CC0 Public DomainA new study led by researchers at The University of Texas MD Anderson Cancer, University of California, Irvine

Updated on:February 24,2024

Novel stem cell culture system could lead to future therapies for a variety of disorders

byUT Southwestern Medical CenterCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.008A new study led by UT Southwestern Medical Center molecular biologists presents a novel culture syst

Updated on: January 15,2024

Novel stem cell culture system could lead to future therapies for a variety of disorders

byUT Southwestern Medical CenterCredit:Cell(2023). DOI: 10.1016/j.cell.2023.11.008A new study led by UT Southwestern Medical Center molecular biologists presents a novel culture syst

Updated on:January 15,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on: January 30,2024

Glass filters developed to separate tumor cells from blood may increase efficiency of blood tests for cancer

by Nagoya UniversityThe experimental setup to capture CTCs and CAFs. (a) Schematic of the experimental setup to capture CTCs and CAFs. (b) Photograph of the experimental setup around the glass fi

Updated on:January 30,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on: August 28,2024

Scientists create cost-effective, easy-to-use test to categorize a child's cancer and guide better treatment

bySt. Jude Children's Research Hospital(L to R) Co-corresponding author Jeff Klco, MD, PhD, St. Jude Department of Pathology, co-corresponding author Xiaotu Ma, PhD, St. Jude Department of C

Updated on:August 28,2024

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on: December 28,2023

Finding and targeting a tumor's sweet spot to eradicate aggressive form of leukemia

byUniversity of BirminghamCredit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.113568A highly aggressive common form of leukemia which is activated by mutations in signaling molecul

Updated on:December 28,2023

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on: March 30,2024

Metalloimmunotherapy: Combination of cisplatin and STING agonist into one molecule boosts cancer immune response

by Science China PressSchematic illustration of the construction of conjugates I and II. Schematic illustration of the combinational effects on tumors of the PtIV-MSA-2 conjugates. The PtIV-MSA-2

Updated on:March 30,2024

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm

Updated on: March 14,2024

17-gene signature linked to remission after triple-negative breast cancer treatment

by Susan Murphy,Mayo ClinicCredit: CC0 Public DomainMayo Clinic researchers have discovered a distinctive pattern in a specific set of 17 genes that may be associated with remission after treatm

Updated on:March 14,2024